Information  X 
Enter a valid email address

Assura plc (AGR)

  Print      Mail a friend

Wednesday 03 July, 2019

Assura plc

PDMR Notification

RNS Number : 4072E
Assura PLC
03 July 2019
 

  3 July 2019

Assura plc

("the Company")

Notification of transactions by Persons Discharging Managerial Responsibilities ("PDMRs")

The Company announces that on 2nd July 2019 the following named PDMRs were granted the following share awards over ordinary shares of 10 pence each in the Company under the Company's Performance Share Plan ("PSP").

 

PDMR

Position

Number of Share Awards Granted

Jonathan Murphy

CEO

927,714

Jayne Cottam

CFO

521,398

Orla Ball

Company Secretary

90,031

 

These awards are subject to two performance conditions which will be determined after the 2021/22 financial year.  50% of the award shares are subject to an absolute Total Shareholder Return ("TSR") performance condition, and the remaining 50% of the award shares are subject to an absolute earnings per share growth ("EPS") performance condition.  Details of the TSR and EPS performance conditions are set out in the Company's Directors' Remuneration Report for 2018/19.

The Notification of Dealing Form for each PDMR can be found below.

This notification is made in accordance with the Market Abuse Regulation.

 

Notification of dealing form

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Jonathan Murphy

2

Reason for the notification

 

a)

Position/status

 

CEO

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

Share options over ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

 

Grant of options under the PSP

 

 

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£NIL GBP

 

927,714

 

 

 

d)

Aggregated information

 

-      Aggregated volume

 

-    Price

 

 

 

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£NIL GBP

 

 

927,714

 

£NIL GBP

e)

Date of the transaction

 

2 July 2019

f)

Place of the transaction

 

XLON

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Jayne Cottam

2

Reason for the notification

 

a)

Position/status

 

CFO

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

Share options over ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

 

Grant of options under the PSP

 

 

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£NIL GBP

 

521,398

 

 

 

d)

Aggregated information

 

-      Aggregated volume

 

-    Price

 

 

 

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£NIL GBP

 

 

521,398

 

£NIL GBP

e)

Date of the transaction

 

2 July 2019

f)

Place of the transaction

 

XLON

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Orla Ball

2

Reason for the notification

 

a)

Position/status

 

Company Secretary

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

Share options over ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

 

Grant of options under the PSP

 

 

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£NIL GBP

 

90,031

 

 

 

d)

Aggregated information

 

-      Aggregated volume

 

-    Price

 

 

 

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£NIL GBP

 

 

90,031

 

£NIL GBP

e)

Date of the transaction

 

2 July 2019

f)

Place of the transaction

 

XLON

 

For more information, please contact:

Assura plc

Tel: 01925 420660

Orla Ball, Company Secretary


David Purcell, Head of Financial Reporting


Finsbury

Tel: 0207 251 3801

Gordon Simpson


 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2019, Assura's property portfolio was valued at £1,979 million.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHKMGGNDFLGLZM

a d v e r t i s e m e n t